On Chemball

My Chemball

As Supplier

My RFQ Manage Products

As Buyer

My RFQ Post RFQ

My Account

+86-571-8627 3270

Hiray Pharmaceutical (Jingmen) Co.,Ltd.

5 YRS

Hubei, China

CNY 500 Million

139860 m²

Less than 50 people

Main Products: Avatrombopag / Urapidil / Peramivir / Dapagliflozin / Blonanserin / Roxatidine / Linezolid / Olaparib

Hubei, China

Contact Supplier

Home Company Profile Contact Us Post Buying Request

Dapagliflozin / CAS 461432-26-8

OVERVIEW

Packaging

1 KG/BOTTLE

Lead Time

14-30 days

REQUEST A QUOTATION

Submit

Get Free Samples

Less than 1KG required

DESCRIPTION

English Name: Dapagliflozin

CAS No.: 461432-26-8

Molecular formula: C21H25ClO6

Molecular weight: 408.88

EINECS No.: 639-683-0

Boiling point: 609.0 ± 55.0 ° C (predicted)

Density: 1.349

Objective: dapagliflozin (ForxigaTM), a new antidiabetic drug developed by Bristol Myers Squibb and AstraZeneca, was approved by the European Medicines Agency (EMA) in November 12, 2012. It is the first SGLT2 inhibitor approved to be marketed for the treatment of type 2 diabetes. It can be an important choice in the treatment of diabetic drugs. It can be used as an auxiliary diet and exercise to improve blood glucose control in adults with type 2 diabetes.

Typical Properties

Dagglitazin is a sodium glucose cotransporter 2 inhibitor (sglt2i), which is a new oral hypoglycemic drug. It can inhibit SGLT2 activity, inhibit sodium glucose reabsorption in proximal renal tubules, promote urinary glucose excretion, and reduce blood glucose concentration.

CAS No.

461432-26-8

Formula

C21H25ClO6

Molecular Mass

408.87300

Exact Mass

408.13400

PSA

99.38000

Logp

1.84440

IUPAC

(2S,3R,4R,5S,6R)-2-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol

SMILES

CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)C3C(C(C(C(O3)CO)O)O)O)Cl

Matter Classification

organic

GET SAMPLE